SPHK2 (sphingosine kinase 2)

2009-06-01  

Identity

HGNC
LOCATION
19q13.33
LOCUSID
ALIAS
SK
FUSION GENES

Other Information

Locus ID:

NCBI: 56848
MIM: 607092
HGNC: 18859
Ensembl: ENSG00000063176

Variants:

dbSNP: 56848
ClinVar: 56848
TCGA: ENSG00000063176
COSMIC: SPHK2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000063176ENST00000245222Q9NRA0
ENSG00000063176ENST00000245222A0A024QZH5
ENSG00000063176ENST00000340932E9PCV4
ENSG00000063176ENST00000426514E7ET12
ENSG00000063176ENST00000593308M0QZP3
ENSG00000063176ENST00000597434A0A075B7A1
ENSG00000063176ENST00000598088Q9NRA0
ENSG00000063176ENST00000598088A0A024QZH5
ENSG00000063176ENST00000599029M0R344
ENSG00000063176ENST00000599748Q9NRA0
ENSG00000063176ENST00000600537Q9NRA0
ENSG00000063176ENST00000601704M0QXX5
ENSG00000063176ENST00000601712M0R0E9

Expression (GTEx)

0
5
10
15
20
25
30
35

Pathways

PathwaySourceExternal ID
Sphingolipid metabolismKEGGko00600
Calcium signaling pathwayKEGGko04020
VEGF signaling pathwayKEGGko04370
Sphingolipid metabolismKEGGhsa00600
Calcium signaling pathwayKEGGhsa04020
VEGF signaling pathwayKEGGhsa04370
Fc gamma R-mediated phagocytosisKEGGko04666
Fc gamma R-mediated phagocytosisKEGGhsa04666
Metabolic pathwaysKEGGhsa01100
TuberculosisKEGGko05152
TuberculosisKEGGhsa05152
Sphingosine degradationKEGGhsa_M00100
Sphingosine degradationKEGGM00100
Sphingolipid signaling pathwayKEGGhsa04071
Sphingolipid signaling pathwayKEGGko04071
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Sphingolipid metabolismREACTOMER-HSA-428157
Sphingolipid de novo biosynthesisREACTOMER-HSA-1660661
Phospholipase D signaling pathwayKEGGko04072
Phospholipase D signaling pathwayKEGGhsa04072
Apelin signaling pathwayKEGGhsa04371

References

Pubmed IDYearTitleCitations
378983772024Accumulation of sphingosine kinase 2 protein induces malignant transformation in oral keratinocytes associated with stemness, autophagy, senescence, and proliferation.0
380489702024The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents.1
384878842024YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis.0
378983772024Accumulation of sphingosine kinase 2 protein induces malignant transformation in oral keratinocytes associated with stemness, autophagy, senescence, and proliferation.0
380489702024The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents.1
384878842024YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis.0
364087242023Sphingosine kinase 2 regulates insulin receptor trafficking in hepatocytes.0
369754442023Inhibition of Sphingosine Kinase 2 Results in PARK2-Mediated Mitophagy and Induces Apoptosis in Multiple Myeloma.2
364087242023Sphingosine kinase 2 regulates insulin receptor trafficking in hepatocytes.0
369754442023Inhibition of Sphingosine Kinase 2 Results in PARK2-Mediated Mitophagy and Induces Apoptosis in Multiple Myeloma.2
350882242022miR-153-3p Attenuates the Development of Gastric Cancer by Suppressing SphK2.2
353940452022Upregulated flotillins and sphingosine kinase 2 derail AXL vesicular traffic to promote epithelial-mesenchymal transition.3
358342712022Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.3
360702942022Enzymatic independent role of sphingosine kinase 2 in regulating the expression of type I interferon during influenza A virus infection.2
350882242022miR-153-3p Attenuates the Development of Gastric Cancer by Suppressing SphK2.2

Citation

Dessen P

SPHK2 (sphingosine kinase 2)

Atlas Genet Cytogenet Oncol Haematol. 2009-06-01

Online version: http://atlasgeneticsoncology.org/gene/50985/favicon/css/template-nav.css